Self-invented Intracavitary ECG Wire VS the Commercial System - Certodyn®
iECG
Comparison of the Self-invented Intracavitary ECG Wire With the Commercial System - Certodyn®
1 other identifier
interventional
36
1 country
2
Brief Summary
Peripherally Inserted Central Catheter (PICC) is considered a central venous line placement (CVL) which mandates the confirmation of the tip's location. At present, most CVL's position are confirmed by radiographic method either by in-procedure fluoroscopy or post-insertion x-ray. For CVLs placed from upper body (from internal jugular vein, subclavian veins or upper arm veins), the intracavitary electrocardiogram (iECG) can also be used. Intracavitary ECG are proven effective for tip confirmation and provide some benefits i.e. lower cost, decrease exposure to harmful radiation for care providers and also the patients, require less personals and equipments, provide real-time confirmation as comparable to fluoroscopy, etc. There are several devices and makes of iECG apparatus but B.Braun-Certodyn® remains the only available system in our institution. The limitation is the availability of the Certodyn devices on each locations where CVL will be placed i.e. operating theater, intensive care unit, bedside placement, radiology suite, etc. Since the connecting wire is only supplied in the certain CVL kits under B.Braun brand, this has rendered iECG for other types or makes of CVL or PICC line become even more difficult. Self-invented connector wire for iECG (PS wire) has been made and used effectively in the past few years at Siriraj hospital. The patent registration is underway and the author seek to compare this PS wire against the commercial Certodyn system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 1, 2018
CompletedFirst Posted
Study publicly available on registry
October 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2019
CompletedOctober 9, 2018
October 1, 2018
11 months
October 1, 2018
October 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Signal noise ratio
Measuring the segment of ECG noise (if exists) in millimeters compare to the total ECG segment. Compare this signal noise ratio between the baseline surface ECG, the self-invented wire derived iECG and the Certodyn derived iECG.
10 minutes
Secondary Outcomes (1)
The amplitude of giant P Wave
5 minutes
Study Arms (2)
PS wire
EXPERIMENTALself-invented iECG wire
Certodyn
ACTIVE COMPARATORCommercially available iECG system - Certodyn
Interventions
The wiring connection used to convey ECG signal from inside the body
Eligibility Criteria
You may qualify if:
- Patient age 18 years and above.
- Requires PICC line insertion from upper torso.
You may not qualify if:
- Children younger than 18 years.
- Patient with atrial fibrillation or other rhythms not generated from intrinsic SA node i.e. pacer, atrial fibrillation, etc.
- Unstable hemodynamic.
- Patient with history arrhythmias.
- Patient with HR \> 120 bpm.
- Patients with hypercoagulable state.
- Allergy to heparin.
- Patients with known heparin induced thrombocytopenia.
- Patients with known Creutzfeldt-Jakob Disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Siriraj hospital, Mahidol university
Bangkok Noi, Bangkok, 10700, Thailand
Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital
Bangkok, 10700, Thailand
Related Publications (1)
1. Oster, D.D. "Improving ECG trace quality." Biomedical Instrumentation & Technology, 2000; 34: 219-222. 2. Corsten SA, van Dijk B, Bakker NC, de Lange JJ, Scheffer GJ. Central venous catheter placement using the ECG-guided Cavafix-Certodyn SD catheter. J Clin Anesth. 1994; 6(6): 469-72. 3. Pittiruti M, La Greca A, Scoppettuolo G. The electrocardiographic method for positioning the tip of central venous catheters. J Vasc Access. 2011; 12(4): 280-91. 4. Pittiruti M, Bertollo D, Briglia E, Buononato M, Capozzoli G, De Simone L, La Greca A, Pelagatti C, Sette P. The intracavitory ECG method for positioning the tip of central venous catheters: results of an italian multicenter study. J Vasc Access. 2012; 13(3):357-65. 5. Wang G, Guo L, Jiang B, Huang M, Zhang J, Qin Y. Factors Influencing Intracavitory Electrocardiographic P-Wave Changes during Central Venous Catheter Placement. PLoS One. 201510(4):e0124846. 6. Yuan L, Li R, Meng A, Feng Y, Wu X, Yang Y, et al. Superior success rate of intracavitory electrocardiogram guidance for peripherally inserted central catheter placement in patients with cancer: A randomized open-label controlled multi center study. PLoO One. 2017; 12(3):e0171630.
BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Prasert Sawasdiwipachai, MD
Anesthesiology department Siriraj hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- unlabeled ECG print
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 1, 2018
First Posted
October 5, 2018
Study Start
August 1, 2018
Primary Completion
June 30, 2019
Study Completion
October 31, 2019
Last Updated
October 9, 2018
Record last verified: 2018-10